Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Nutricia Research, Utrecht, The Netherlands.
Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):475-483. doi: 10.1007/s10096-018-3193-y. Epub 2018 Jan 24.
Antibiotic treatment is common practice in the neonatal ward for the prevention and treatment of sepsis, which is one of the leading causes of mortality and morbidity in preterm infants. Although the effect of antibiotic treatment on microbiota development is well recognised, little attention has been paid to treatment duration. We studied the effect of short and long intravenous antibiotic administration on intestinal microbiota development in preterm infants. Faecal samples from 15 preterm infants (35 ± 1 weeks gestation and 2871 ± 260 g birth weight) exposed to no, short (≤ 3 days) or long (≥ 5 days) treatment with amoxicillin/ceftazidime were collected during the first six postnatal weeks. Microbiota composition was determined through 16S rRNA gene sequencing and by quantitative polymerase chain reaction (qPCR). Short and long antibiotic treat ment significantly lowered the abundance of Bifidobacterium right after treatment (p = 0.027) till postnatal week three (p = 0.028). Long treatment caused Bifidobacterium abundance to remain decreased till postnatal week six (p = 0.009). Antibiotic treatment was effective against members of the Enterobacteriaceae family, but allowed Enterococcus to thrive and remain dominant for up to two weeks after antibiotic treatment discontinuation. Community richness and diversity were not affected by antibiotic treatment, but were positively associated with postnatal age (p < 0.023) and with abundance of Bifidobacterium (p = 0.003). Intravenous antibiotic administration during the first postnatal week greatly affects the infant's gastrointestinal microbiota. However, quick antibiotic treatment cessation allows for its recovery. Disturbances in microbiota development caused by short and, more extensively, by long antibiotic treatment could affect healthy development of the infant via interference with maturation of the immune system and gastrointestinal tract.
抗生素治疗在新生儿病房中常用于预防和治疗败血症,败血症是早产儿死亡和发病的主要原因之一。尽管抗生素治疗对微生物群发展的影响已得到充分认识,但对治疗持续时间的关注较少。我们研究了短时间和长时间静脉内使用抗生素对早产儿肠道微生物群发展的影响。从 15 名接受阿莫西林/头孢他啶无、短(≤3 天)或长(≥5 天)治疗的早产儿(35±1 周胎龄和 2871±260 克出生体重)的粪便样本中收集了在出生后前六周内的样本。通过 16S rRNA 基因测序和定量聚合酶链反应(qPCR)来确定微生物组组成。短时间和长时间的抗生素治疗在治疗后立即显著降低双歧杆菌的丰度(p=0.027),直到出生后第三周(p=0.028)。长时间的治疗导致双歧杆菌的丰度一直持续到出生后第六周(p=0.009)。抗生素治疗对肠杆菌科的成员有效,但允许肠球菌在抗生素治疗停止后长达两周内继续繁殖并保持优势。抗生素治疗不会影响群落丰富度和多样性,但与出生后年龄呈正相关(p<0.023),与双歧杆菌的丰度呈正相关(p=0.003)。出生后第一周内的静脉内抗生素给药极大地影响婴儿的胃肠道微生物群。然而,快速停止抗生素治疗可以使其恢复。短时间和更广泛的长时间抗生素治疗引起的微生物群发展紊乱可能会通过干扰免疫系统和胃肠道的成熟来影响婴儿的健康发育。